Literature DB >> 3268152

Alveolar soft part sarcoma of the pituitary gland with secondary involvement of the right cerebral ventricle.

G T Bots1, C C Tijssen, D Wijnalda, J L Teepen.   

Abstract

An alveolar soft part sarcoma localised in the pituitary gland extended into the suprasellar region. Three years after surgical removal there was a recurrency in the occipital horn of the right cerebral ventricle. This type of tumour predominantly occurs in the limbs and has never been reported in the pituitary region.

Entities:  

Mesh：

Year:  1988        PMID： 3268152     DOI： 10.3109/02688698808999666

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN： 0268-8697            Impact factor:   1.596


  5 in total

1.  Metastatic alveolar soft-part sarcoma of the intracranial skull base: case report.

Authors:  David B Cohen; David M Jones; Allan H Fergus; Jiang Qian; Marc S Schwartz
Journal:  Skull Base       Date:  2002-02

2.  Synovial sarcoma of the sellar region.

Authors:  Bernd W Scheithauer; Ana Isabel Silva; Keith Kattner; Jason Seibly; Andre M Oliveira; Kalman Kovacs
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

Review 3.  Sarcomas of the sellar region: a systematic review.

Authors:  Fernando Guerrero-Pérez; Noemi Vidal; Macarena López-Vázquez; Reinaldo Sánchez-Barrera; Juan José Sánchez-Fernández; Alberto Torres-Díaz; Nuria Vilarrasa; Carles Villabona
Journal:  Pituitary       Date:  2021-02       Impact factor: 4.107

Review 4.  Combined sellar fibrosarcoma and prolactinoma with neuronal metaplasia: report of a case unassociated with radiotherapy.

Authors:  Mario Moro; Caterina Giannini; Bernd W Scheithauer; Ricardo V Lloyd; Paul Restall; Carl Eagleton; Andrew J Law; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

5.  Clinical characteristics and outcomes of primary intracranial alveolar soft-part sarcoma: A case report.

Authors:  Jun-Yu Chen; Bo Cen; Fei Hu; Yong Qiu; Guo-Min Xiao; Jun-Ge Zhou; Fang-Cheng Zhang
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.